Display options
Share it on

Pulm Circ. 2016 Mar;6(1):136-42. doi: 10.1086/685112.

An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature.

Pulmonary circulation

Mili V Mehta, Daniel K Manson, Evelyn M Horn, Jennifer Haythe

Affiliations

  1. Columbia University College of Physicians and Surgeons, New York, New York, USA.
  2. Division of Cardiology, Weill Cornell Medical Center, New York, New York, USA.
  3. Division of Cardiology, Columbia University Medical Center, New York, New York, USA.

PMID: 27162622 PMCID: PMC4860549 DOI: 10.1086/685112

Abstract

Pulmonary arterial hypertension (PAH) is a known complication of rheumatologic diseases, but it is only rarely associated with adult-onset Still's disease (AOSD). We describe the case of a 30-year-old woman who presented in a pulmonary hypertension crisis and was found to have underlying AOSD with PAH and nonspecific interstitial pneumonia (NSIP) with a course complicated by macrophage activation syndrome (MAS). She dramatically improved with steroids, cyclosporine A, and anakinra, with total resolution of the MAS and significant improvement of her pulmonary arterial pressures. While there are only select case reports of AOSD associated with PAH, this is the first reported case of (1) AOSD complicated by both PAH and MAS and (2) AOSD complicated by biopsy-proven NSIP. Clinically, this case highlights the efficacy of immunosuppressive agents in the treatment of PAH and MAS from underlying AOSD and supports their use in this setting.

Keywords: anakinra; pulmonary arterial hypertension; secondary hemophagocytic lymphohistiocytosis

References

  1. Annu Rev Med. 2015;66:145-59 - PubMed
  2. Can Respir J. 2010 Nov-Dec;17(6):282-6 - PubMed
  3. Pediatr Blood Cancer. 2007 Feb;48(2):124-31 - PubMed
  4. Prog Cardiovasc Dis. 2002 Nov-Dec;45(3):225-34 - PubMed
  5. J Rheumatol. 2011 Apr;38(4):764-8 - PubMed
  6. Clin Rheumatol. 2013 Mar;32 Suppl 1:S1-2 - PubMed
  7. Curr Respir Care Rep. 2012 Sep 21;1:224-232 - PubMed
  8. Nat Clin Pract Rheumatol. 2008 Nov;4(11):615-20 - PubMed
  9. J Rheumatol. 1992 Mar;19(3):424-30 - PubMed
  10. Clin Rheumatol. 2007 Aug;26(8):1359-61 - PubMed
  11. Rheumatol Int. 2013 Jul;33(7):1655-67 - PubMed
  12. Ann Rheum Dis. 1983 Aug;42(4):452-54 - PubMed
  13. J Rheumatol. 2010 Apr;37(4):879-80 - PubMed
  14. J Pediatr. 2005 May;146(5):598-604 - PubMed
  15. J Rheumatol. 1996 Mar;23(3):495-7 - PubMed
  16. Best Pract Res Clin Rheumatol. 2014 Apr;28(2):277-92 - PubMed
  17. Arthritis Rheumatol. 2014 Oct;66(10):2871-80 - PubMed
  18. Chest. 2010 Dec;138(6):1383-94 - PubMed
  19. Arthritis Rheumatol. 2014 Nov;66(11):3160-9 - PubMed
  20. Int J Rheum Dis. 2014 Mar;17 (3):336-40 - PubMed
  21. J Clin Rheumatol. 2011 Jan;17(1):23-7 - PubMed
  22. Rheumatol Int. 2011 Jul;31(7):923-7 - PubMed
  23. Rheumatology (Oxford). 2011 Feb;50(2):417-9 - PubMed
  24. J Rheumatol. 2002 Feb;29(2):282-7 - PubMed
  25. Case Rep Rheumatol. 2012;2012:537613 - PubMed
  26. Semin Arthritis Rheum. 2015 Feb;44(4):417-22 - PubMed
  27. N Engl J Med. 2002 Mar 21;346(12):896-903 - PubMed
  28. Pediatr Blood Cancer. 2008 Feb;50(2):192-4 - PubMed
  29. Chest. 2012 Jan;141(1):210-21 - PubMed
  30. Ryumachi. 1990 Feb;30(1):45-52 - PubMed
  31. Arch Intern Med. 1986 Dec;146(12 ):2409-10 - PubMed
  32. Chest. 2006 Jul;130(1):182-9 - PubMed

Publication Types